Sanofi SA (SNY) Gains Daily News Effect Rating of 0.13

Sanofi SA (SNY) Gains Daily News Effect Rating of 0.13

Media headlines about Sanofi SA (NYSE:SNY) have trended somewhat positive this week, AlphaOne Sentiment Analysis reports. AlphaOne, a subsidiary of Accern, scores the sentiment of news coverage by analyzing more than 20 million blog and news sources in real-time. AlphaOne ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Sanofi SA earned a daily sentiment score of 0.13 on AlphaOne’s scale. AlphaOne also assigned news coverage about the company an impact score of 14 out of 100, indicating that recent news coverage is very unlikely to have an impact on the company’s share price in the near future.

These are some of the news articles that may have impacted AlphaOne Sentiment’s analysis:

Several brokerages recently weighed in on SNY. Zacks Investment Research downgraded shares of Sanofi SA from a “buy” rating to a “hold” rating in a research note on Tuesday, April 25th. JPMorgan Chase & Co. reissued a “sell” rating on shares of Sanofi SA in a research note on Wednesday, April 5th. HSBC Holdings plc downgraded shares of Sanofi SA from a “hold” rating to a “reduce” rating in a research note on Friday, April 7th. Barclays PLC began coverage on shares of Sanofi SA in a research note on Tuesday, March 7th. They issued an “underweight” rating for the company. Finally, TheStreet raised shares of Sanofi SA from a “c+” rating to a “b-” rating in a research note on Monday, April 24th. Two equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $64.33.

Sanofi SA (NYSE:SNY) traded down 0.63% on Thursday, hitting $49.28. 709,269 shares of the stock were exchanged. Sanofi SA has a 52 week low of $36.81 and a 52 week high of $50.24. The company has a market cap of $124.46 billion, a PE ratio of 12.27 and a beta of 0.98. The company’s 50-day moving average is $47.79 and its 200-day moving average is $43.32.

Sanofi SA (NYSE:SNY) last posted its quarterly earnings results on Friday, April 28th. The company reported $0.76 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.73 by $0.03. Sanofi SA had a return on equity of 26.37% and a net margin of 13.66%. The company had revenue of $8.65 billion during the quarter, compared to the consensus estimate of $8.40 billion. Sanofi SA’s revenue for the quarter was up 1.2% compared to the same quarter last year. On average, analysts predict that Sanofi SA will post $3.15 earnings per share for the current year.

Sanofi SA Company Profile

Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. The Company’s segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the Company’s pharmaceuticals operations.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “SNY”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Related posts

Leave a Comment